Caredx to participate in upcoming jefferies healthcare conference

South san francisco, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will participate in the jefferies healthcare conference on june 9th, 2022. caredx's management is scheduled to present at the jefferies healthcare conference on thursday, june 9th, 2022, at 2:00 pm et.
CDNA Ratings Summary
CDNA Quant Ranking